These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25255234)

  • 21. Intestinal microbiota in inflammatory bowel disease: friend of foe?
    Fava F; Danese S
    World J Gastroenterol; 2011 Feb; 17(5):557-66. PubMed ID: 21350704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis.
    Rogier R; Ederveen THA; Boekhorst J; Wopereis H; Scher JU; Manasson J; Frambach SJCM; Knol J; Garssen J; van der Kraan PM; Koenders MI; van den Berg WB; van Hijum SAFT; Abdollahi-Roodsaz S
    Microbiome; 2017 Jun; 5(1):63. PubMed ID: 28645307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
    Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
    J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
    Bamias G; Jia LG; Cominelli F
    Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.
    He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z
    Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.
    Wu W; Chen F; Liu Z; Cong Y
    Inflamm Bowel Dis; 2016 Jun; 22(6):1473-82. PubMed ID: 27057688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
    Larabi A; Barnich N; Nguyen HTT
    Autophagy; 2020 Jan; 16(1):38-51. PubMed ID: 31286804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of T
    Brockmann L; Giannou AD; Gagliani N; Huber S
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microbiota and inflammatory bowel disease: insights from animal models.
    Peloquin JM; Nguyen DD
    Anaerobe; 2013 Dec; 24():102-6. PubMed ID: 23603043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Th17 plasticity and its relevance to inflammatory bowel disease.
    Ueno A; Jeffery L; Kobayashi T; Hibi T; Ghosh S; Jijon H
    J Autoimmun; 2018 Feb; 87():38-49. PubMed ID: 29290521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD.
    Wu W; He C; Liu C; Cao AT; Xue X; Evans-Marin HL; Sun M; Fang L; Yao S; Pinchuk IV; Powell DW; Liu Z; Cong Y
    Gut; 2015 Nov; 64(11):1755-64. PubMed ID: 25281418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease.
    Liu ZJ; Yadav PK; Su JL; Wang JS; Fei K
    World J Gastroenterol; 2009 Dec; 15(46):5784-8. PubMed ID: 19998498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokines and intestinal inflammation.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2016 Nov; 32(6):437-442. PubMed ID: 27673380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.
    Kim DJ; Kim KS; Song MY; Seo SH; Kim SJ; Yang BG; Jang MH; Sung YC
    Clin Immunol; 2012 Sep; 144(3):190-9. PubMed ID: 22836084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses.
    Maerz JK; Trostel C; Lange A; Parusel R; Michaelis L; Schäfer A; Yao H; Löw HC; Frick JS
    Front Immunol; 2019; 10():3093. PubMed ID: 32038631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!
    Pantazi E; Powell N
    Front Immunol; 2019; 10():676. PubMed ID: 31024537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications.
    Hörmannsperger G; Clavel T; Hoffmann M; Reiff C; Kelly D; Loh G; Blaut M; Hölzlwimmer G; Haller D
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S10-5. PubMed ID: 20562631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.